Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Arlon

7 clinical trials in Arlon, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Arlon at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Arlon

Open in trial search
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Hamilton Health Sciences Corporation

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Unicancer
Countries:BelgiumBelgium
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Unicancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:University Of Ottawa Heart Institute

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Arlon

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on atrial fibrillation and stroke prevention, examining advanced anticoagulation strategies for patients following catheter ablation procedures.

  • Post-ablation care optimization
  • Stroke risk reduction
  • Anticoagulation management

Current trials are evaluating novel therapeutic approaches including the assessment of milvexian compared to standard treatments for preventing cardioembolic events.

02 Oncology - Breast Cancer

Comprehensive research into hormone receptor-positive breast cancer treatment, particularly focusing on elderly patients and personalized therapeutic approaches.

  • Hormone therapy optimization
  • Genomic-guided treatment
  • Targeted therapies

Studies are exploring combination treatments using everolimus with hormone therapy for high-risk patients with ER-positive, HER2-negative breast cancer.

03 Precision Medicine

Advanced research utilizing genomic profiling to guide treatment decisions in cancer care, with special attention to elderly patient populations.

  • Personalized treatment strategies
  • Risk assessment protocols
  • Treatment optimization

Current investigations focus on tailoring therapeutic approaches based on specific disease characteristics and patient profiles.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.